The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022 at 08:31 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Keytruda ...
